Acute Kidney Injury Treatment Market size is estimated to be valued at US$ 1,857.8 million in 2021 and is expected to exhibit a CAGR of 7.2% between 2021 and 2028

Overview:

Acute kidney injury (AKI) is a condition that affects the kidneys and is usually diagnosed based on clinical history and laboratory data. Symptoms include rapid reductions in urine output and in renal function. it is most often caused by a systemic disease, a crush injury, a drug overdose, or some other reason. Depending on the causes, acute kidney injury treatment may include restoring blood flow to the kidneys and removing any blockage in the urinary tract. In severe cases, AKI can lead to chronic kidney problems that require permanent dialysis or a kidney transplant. Although most people suffering from AKI experience temporary damage, there are other treatments for chronic renal problems.

Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4691

Market Dynamics:

Increase in the technological development and R&D activities are expected to augment growth of the global acute kidney injury treatment market during the forecast period. For instance, in December 2021, scientists at the University of Groningen, the Netherlands, found a lead compound, SUL-138 derived from 6-chromanol for the acute kidney injury treatment. The scientists found that the compound had no cardiovascular or respiratory effects when tested in mice.

However, high cost of treatment and lack of awareness in people regarding the treatment of acute kidney injury is expected to restrict growth of the global acute kidney injury treatment market during the forecast period.

Impact of COVID-19:

The global acute kidney injury treatment market was adversely affected due to the outbreak of COVID-19 pandemic. Many of the countries employed strict lockdown regulations, causing inactivity in various industries, later disrupting the manufacturing, supply chain activities of these industries including pharmaceutical industry, which further affected the market in the discussion. However, the introduction of novel vaccines and decrease in the number of COVID-19 cases is expected to support the global acute kidney injury treatment market to recover from the negative impact of the pandemic.

Buy-Now This Report and get UPTO 80% DISCOUNT

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/4691

Key Takeaways:

• The global acute kidney injury treatment market is expected to expand, exhibiting a CAGR of 7.2% over the forecast period due to advancement in the treatment of acute kidney injury. For instance, in July 2019, scientists at DeepMind Health, developed an artificial-intelligence (AI) algorithm for the treatment of acute kidney injury. The algorithm is designed for identifying factors suggesting risk of acute kidney injury in patients, and for predicting it 48 hours before its occurrence.

• North America is expected to witness robust growth in the global acute kidney injury treatment market during the forecast period due to availability of well-established and developed healthcare infrastructure in the region.

• Key players active in the global acute kidney injury treatment market are Baxter International, Inc., AM-Pharma, Angion Biomedia Corp., Fresenius Medical Care AG & Co. KgaA., Asahi Kasei Medical, Quark Pharmaceuticals, Inc., LG Chem., and B.Braun Melsungen AG.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4691

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Type 
     • Market Snapshot, By Treatment
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
   • Impact Analysis
   • Pipeline Analysis
   • Regulatory Scenario
   • Market Trends
   • Key Developments
   • Epidemiology
   • PEST Analysis
   • Brand Analysis
4. Global Acute Kidney Injury Treatment Market– Impact of Coronavirus (COVID-19) Pandemic
   • Economic Impact
   • Impact on Clinical Trials and Drug Development
5. Global Acute Kidney Injury Treatment Market, By Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Prerenal Acute Kidney Injury
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Intrinsic Renal Acute Kidney Injury
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Postrenal Acute Kidney Injury
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
6. Global Acute Kidney Injury Treatment Market, By Treatment, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
7. Global Acute Kidney Injury Treatment Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
8. Global Acute Kidney Injury Treatment Market, By Region, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2017–2028
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Brazil
     • Mexico
     • Argentina
     • Rest of Latin America
   • Europe
     • U.K.
     • Germany
     • France
     • Italy
     • Spain
     • Russia
     • Rest of Europe
   • Asia Pacific
     • China
     • India
     • Japan
     • Australia
     • South Korea
     • ASEAN
     • Rest of Asia Pacific
   • Middle East
     • GCC
     • Israel
     • Rest of Middle East
   • Africa
     • North Africa
     • Central Africa
     • South Africa